Tetra Radar · FDA Approvals · Decision date

deramiocel: FDA decision date

Dyne Therapeutics Inc (DYN) · 22 August 2026

Capricor Therapeutics’ BLA application for its cell therapy deramiocel is currently under FDA review and an FDA Advisory Committee meeting is scheduled for July 29, 2026 prior to the PDUFA date of August 22, 2026.

Source: 10-Q of 29 July 2026

The date has passed; Tetra Radar has not recorded an approval.

Dyne Therapeutics Inc on Tetra Radar

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.